Adaptive contouring of the target volume and organs at risk

Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management

Volumn , Issue , 2011, Pages 99-118

  Petrič, Primož ^a   Pötter, Richard ^b   Van Limbergen, Erik ^c   Haie Meder, Christine ^d  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857997681     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-68958-4_9     Document Type: Chapter

References (97)

1. ICRU, International Commission of Radiation Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynaecology. ICRU report 38, Bethesda, MD; 1985.
2. Pötter R., Van Limbergen E, Wambersie A. Reporting in brachytherapy. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors. The GEC ESTRO handbook of brachytherapy. Brussels: European Society of Therapeutic Radiology and Oncology; 2002. p. 153-215.
3. Pötter R., Gerbaulet A, Haie-Meder C. Endometrial cancer. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors. The GEC ESTRO handbook of brachytherapy. Brussels: European Society of Therapeutic Radiology and Oncology; 2002. p. 365-401.
4. Mock U, Knocke TH, Fellner C, et al. Comparison of different application systems and CT-assisted treatment planning procedures in the treatment of primary endometrium carcinoma: Is it technically possible to include the whole uterus volume in the volume treated by brachytherapy? Strahlenther Onkol. 1998; 174: 320-8.
5. Kim RY, Pareek P. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms. Brachytherapy. 2003; 2: 200-6.
6. Datta NR, Srivastava A, Maria Das KJ, et al. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer. Brachytherapy. 2006; 5: 223-9.
7. De Brabandere M., Mousa AG, Nulens A, et al. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol. 2008; 88(2): 217-26.
8. Hudej R, Petric P, Burger J. Standard versus 3D optimized MRI-based planning for uterine cervix cancer brachyradiotherapy - the Ljubljana experience. Zbornik predavanj, konferenca MEDICON, Ljubljana; 2007.
9. Lindegaard JC, Tanderup K, Nielsen S.K., et al. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2008; 71(3): 756-64.
10. Petric P, Hudej R, Rogelj P., et al. Frequency-distribution mapping of HR CTV in locally advanced cervix cancer: a new tool for development of novel brachytherapy techniques. Radiother Oncol. 2009; 91 Suppl 1: 18-9.
11. Fletcher GH, Hamburger AD. Female pelvis. Squamous cell carcinoma of the uterine cervix. In: Fletcher GH, editor. Textbook of radiotherapy. 3rd ed. Philadelphia: Lea & Febiger; 1980. p. 720-89.
12. Gerbaulet A, Pötter R, Haie-Meder C. Cervix cancer. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors. The GEC ESTRO handbook of brachytherapy. Brussels: European Society of Therapeutic Radiology and Oncology; 2002. p. 301-63.
13. Horiot JC, Pigneux J, Pourquier H. Radiotherapy alone in carcinoma of intact uterine cervix according to Fletcher guidelines: A French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys. 1988; 14(4): 605-11.
14. Ito H, Kutuki S, Nishiguchi I., et al. Radiotherapy for cervical cancer with high dose rate brachytherapy-correlation between tumour size, dose and failure. Radiother Oncol. 1994; 31: 240-7.
15. Perez CA, Breaux S, Bedwinek J.M., et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer. 1992; 69: 2796-806.
16. Pernot M, Hoffstetter S, Peiffert D., et al. Statistical study of a series of 672 cases of carcinoma of the uterine cervix. Results and complications according to age and modalities of treatment. Bull Cancer. 1995; 82(7): 568-81.
17. Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys. 1999; 43: 359-66.
18. Pötter R., Knocke TH, Fellner C, et al. Definitive radiotherapy based on HDR brachytherapy with Iridium - 192 in cervix cancer - report on the recent Vienna university hospital experience (1993-1997) compared to the preceding period, referring to ICRU 38 recommendations. Bull Cancer Radiother. 2000; 4: 159-72.
19. Visser AG, Symonds RP. Dose and volume specification for reporting gynaecological brachytherapy: time for a change. Radiother Oncol. 2001; 58: 1-4.
20. Barillot I, Horiot JC, Maingon P, et al. Maximum and mean bladder dose defined from ultra-sonography. Comparison with the ICRU reference in gynaecological brachytherapy. Radiother Oncol. 1994; 30(3): 231-8.
21. Ling CC, Schell MC, Working K.R., et al. CT-assisted assessment of bladder and rectum dose in gynecological implants. Int J Radiat Oncol Biol Phys. 1987; 13(10): 1577-82.
22. LaVigne SSL, ML MMK, et al. Three-dimensional treatment planning of intracavitary gynaecologic implants: analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys. 1994; 28(1): 277-83.
23. Barillot I, Horiot JC, Maingon P, et al. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies. Int J Radiat Oncol Biol Phys. 2000; 48(1): 189-200.
24. Chen SW, Liang JA, Yeh L.S., et al. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachyther-apy for cervical cancer. Int J Radiat Oncol Biol Phys. 2004; 60(2): 663-71.
25. Ferrigno R, dos Santos Novaes PE, Pelizzon AC, et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys. 2001; 50(5): 1123-35.
26. Kim HJ, Kim S, Ha S.W., et al. Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer? Tumori. 2008; 94(3): 327-32.
27. Ogino I, Kitamura T, Okamoto N., et al. Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix. Int J Radiat Oncol Biol Phys. 1995; 31(4): 725-34.
28. Perez CA, Grigsby PW, Lockett M.A., et al. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys. 1999; 44(4): 855-66.
29. Roeske JC, Mundt AJ, Halpern H, et al. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimteric analysis. Int J Radiat Oncol Biol Phys. 1997; 37(2): 351-8.
30. Boss EA, Barentsz JO, Massuger LFAG, et al. The role of MR imaging in invasive cervical carcinoma (review). Eur Radiol. 2000; 10: 256-70;
31. Subak LL, Hricak H, Powell CB, et al. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995; 86: 43-50.
32. Haie-Meder C., Pötter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005; 74: 235-45.
33. Pötter R., Haie-Mader C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC-ESTRO Working Group: (II): concepts and terms of 3D imaging, radiation physics, radiobiology, and 3D dose volume parameters. Radiother Oncol. 2006; 78: 67-77.
34. Dimopoulos JCA, Schard G, Berger D., et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, patho-anatomical structures and organs at risk. Int J Radiat Oncol Biol Phys. 2006; 64: 1380-8.
35. Dimopoulos JCA, Schirl G, Baldinger A., et al. MRI assessment of cervical cancer for adaptive radiotherapy. Strahlentherapie und Onkologie. 2009; 185(5): 282-7.
36. Kerkhof EM, Raaymakers BW, van der Heide UA, van de Bunt L, Jürgenliemk-Schulz IM, Lagendijk JJ. Online MRI guidance for healthy tissue sparing in patients with cervical cancer: an IMRT planning study. Radiother Oncol. 2008; 88(2): 241-9.
37. Mitchell DG, Snyder B, Coakley F., et al. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verifed by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol. 2006; 24(36): 5687-94.
38. Oszarlak O, Tjalma W, Scheppens E., et al. The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma. Eur Radiol. 2003; 13(10): 2338-45.
39. van de Bunt L, Jurgenliemk-Schulz IM, de Kort GA, Roesink JM, Tersteeg RJ, van der Heide UA. Motion and deformation of the target volumes during IMRT for cervical cancer: what margins do we need? Radiother Oncol. 2008; 88: 233-40.
40. van de Bunt L, van der Heide UA, Ketelaars M, de Kort GA, Jurgenliemk-Schulz IM. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression. Int J Radiat Oncol Biol Phys. 2006; 64: 189-96.
41. Haie-Meder C et al. MRI-based brachytherapy (BT) in the treatment of cervical cancer: experience of the Institut Gustave-Roussy. Radiother Oncol. 2007; 83 Suppl 1:S11-2.
42. Kirisits C, Pötter R, Lang S., et al. Dose and volume parameters for MRI based treatment planning in intracavitary brachytherapy of cervix cancer. Int J Radiation Oncology Biol Phys. 2005; 62(3): 901-11.
43. Pötter R., Dimopoulos J, Georg P., et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol. 2007; 83: 148-55.
44. Viswanathan AN, Cormack R, Holloway C.L., et al. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys. 2006; 66(1): 91-9.
45. Wachter-Gerstner N., Wachter S, Reinstadler E., et al. The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. Radiother Oncol. 2003; 68(1): 51-9.
46. Weitmann HD, Pötter R, Waldhäusl C, et al. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modifed Heyman Packing: clinical experience and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2005; 62(2): 468-78.
47. Bernaschek G, Deutinger J, Kratochwill A. Endosonographic diagnosis of carcinoma. In: Endosonography in obstetrics and gynecology. Berlin, Heidelberg: Springer; 1990. p. 97-121.
48. Davidson MT, Yuen J, D'Souza D, et al. Optimization of high-dose-rate cervix brachytherapy applicator placement: the benefts of intraoperative ultrasound guidance. Brachytherapy. 2008; 7: 248-53.
49. Granai CO, Allee P, Doherty F., et al. Ultrasound used for assessing the in situ position of intrauterine tandems. Gynecol Oncol. 1984; 18(3): 334-8.
50. Mayr NA, Montebello JF, Sorosky J.I., et al. Brachytherapy management of the retroverted uterus using ultrasound-guided implant applicator placement. Brachytherapy. 2005; 4: 24-9.
51. Sahinler I, Cepni I, Colpan D., et al. Tandem application with transvaginal ultrasound guidance. Int J Radiat Oncol Biol Phys. 2004; 59(1): 190-6.
52. Stock RG, Chan K, Terk M., et al. A new technique for performing Syed-Neblett template interstitial implants for gynecologic malignancies using transrectal-ultrasound guidance. Int J Radiat Oncol Biol Phys. 1997; 37: 819-25.
53. Weitmann HD, Knocke TH, Waldhäusl C, et al. Ultrasound-guided interstitial Brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma. Strahlentherapie und Onkologie. 2006; 182: 86-95.
54. Gerbaulet A, Pötter R, Haie-Meder C. Primary vaginal cancer. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors. The GEC ESTRO handbook of brachytherapy. Brussels: European Society of Therapeutic Radiology and Oncology; 2002. p. 153-215.
55. Van Dyk S., Narayan K, Fisher R., Bernshaw D. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound. Int J Radiat Oncol Biol Phys. 2009; 75(1): 64-70.
56. Kapp KS, Stuecklschweiger GF, Kapp D.S., et al. Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal flm, TLD, and CT-assisted techniques. Radiother Oncol. 1992; 24(3): 137-46.
57. Kim RY, Shen S, Duan J. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sig-moid colon, and small bowel. Brachytherapy. 2007; 6(3): 187-94.
58. Pelloski CE, Palmer M, Chronowski G.M., et al. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005; 62(1): 131-7.
59. Sun LM, Huang E Y, Ko SF, et al. Computer-tomography-assisted three-dimensional technique to assess rectal and bladder wall dose in intracavitary brachytherapy for uterine cervical cancer. Radiother Oncol. 2004; 71(3): 333-7.
60. van den Bergh F, Mertens H, Moonen LMF, et al. The use of a transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. Radiother Oncol. 1998; 47: 85-90.
61. Eisbruch A, Johnston CM, Martel M.K., et al. Customized gynecologic interstitial implants: CT-based planning, dose evaluation and optimization aided by laparotomy. Int J Radiat Oncol Biol Phys. 1998; 40(5): 1087-93.
62. Fellner C, Pötter R, Knocke T., et al. A comparison of radiography and computed-tomography-based treatment planning in cervix cancer brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol. 2001; 58: 53-62.
63. Mai J, Rownd J, Erickson B. CT-guided high-dose-rate dose prescription for cervical carcinoma: the importance of uterine wall thickness. Brachytherapy. 2002; 1(1): 27-35.
64. Shin KH, Kim TH, Cho J.K., et al. CT-guided intracavitary radiotherapy for cervical cancer: comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose volume parameters. Int J Radiat Oncol Biol Phys. 2006; 64(1): 197-204.
65. Bond MG, Workman G, Martland J., et al. Dosimetric considerations in the treatment of inoperable endometrial carcinoma by a high dose rate afterloading packing technique. Clin Oncol. 1997; 9(1): 41-7.
66. Bipat S, Glas AS, van der Velden J, et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol. 2003; 91(1): 59-66.
67. Hricak H, Gatsonis C, Coakley F V, et al. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation - ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology. 2007; 245(2): 491-8.
68. Jung DC, Ju W, Choi H.J., et al. The validity of tumour diameter assessed by magnetic resonance imaging and gross specimen with regard to tumour volume in cervical cancer patients. Eur J Cancer. 2008; 44(11): 1524-8.
69. Lukas P, Heuck A. The use of magnetic resonance tomography in cancer of the cervix and uterus. Rontgenpraxis. 1990; 43(12): 439-44.
70. Pötter R., Kovacs G, Haverkamp U. 3D Conformal Therapy in Brachytherapy. 8th International Brachytherapy Conference, Nice 1995. Nucletron-Oldelft, Veenendaal. p. 34-39.
71. Pötter R., Kovacs G, Lenzen B., et al. Technique of MRI assisted brachytherapy treatment planning. Activity. Selectr Brachyther J. 1991; 5(3): 145-8.
72. Pötter R. Modern imaging methods used for treatment planning and quality assurance for combined irradiation of cervix cancer, Workshop Integration of external beam therapy and brachytherapy in the treatment of cervix cancer: clinical, physical and biological aspects. Annual Brachytherapy Meeting GEC-ESTRO Stockholm, 5-7 May 1997; European Society for Therapeutic Radiology and Oncology, Groupe Européen de Curiethérapie 1997; p. 27-39.
73. Schmidt BF, Hirnle P, Kaulich T.W., et al. The value of NMR tomography in the planning of HDR-afterloading brachytherapy in cervical carcinomas: The experience with 41 patients. Rofo. 1991; 155(2): 109-16.
74. Schoeppel SL, Ellis JH, LaVigne M.L., et al. Magnetic resonance imaging during intracavitary gynecologic brachytherapy. Int J Radiat Oncol Biol Phys. 1992; 23(1): 169-74.
75. Tardivon AA, Kinkel K, Lartigau E., et al. MR imaging during intracavitary brachytherapy of vaginal and cervical cancer: preliminary results. Radiographics. 1996; 16(6): 1363-70.
76. Dimopoulos J, Fidarova E, Pötter R. Definitive radiotherapie und radiochemotherapie der vulva und vagina. Onkologe. 2009; 15: 54-63.
77. Dimopoulos J, Schmid M, Berger D et al. MRI-guided BT with EBRT plus chemotherapy for the treatment of locally advanced vaginal cancer. Radiother Oncol. 2009; 91 (Suppl. 1): S18-19.
78. Pötter R. Vaginalkarzinom. In: Strnad V, Pötter R, Kovacs G, editors. Stand und Perspektiven der klinischen Brachytherapie. Bremen: UNI-MED; 2004. p. 114-21.
79. Nag S, Cardenes H, Chang S., et al. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from image-guided brachytherapy working group. Int J radiat Oncol Biol Phys. 2004; 60(4): 1160-72.
80. 18F] fuorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol. 2004; 22: 2167-71.
81. Xue F, Lin LL, Dehdashti F, et al. F-18 fuorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol. 2006; 101: 147-51.
82. Malyapa RS, Mutic S, Low D.A., et al. Physiologic FDG-PET three dimensional brachytherapy treatment planning for cervical cancer. Int J Radiat Oncol Biol Phys. 2002; 54(4): 1140-6.
83. Mutic S, Grigsby PW, Low D.A., et al. PET-guided three-dimensional treatment planning of intracavitary gynecologic implants. Int J Radiat Oncol Biol Phys. 2002; 52(4): 1104-10.
84. Nag S. Controversies and new developments in gynecologic brachytherapy: image-based intracavitary brachytherapy for cervical carcinoma. Semin Radiat Oncol. 2006; 16(3): 164-7.
85. Dimopoulos JC, De Vos V, Berger D, et al. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol. 2009; 91(2): 166-72.
86. Petric P, Hudej R, Rogelj P., et al. 3D T2-weighted fast recovery fast spin echo sequence MRI for target contouring in cervix cancer brachytherapy. Brachytherapy. 2008; 7(2): 109.
87. Berger D, Dimopoulos J, Georg P., et al. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator. Int J Radiat Oncol Biol Phys. 2007; 67(5): 1451-9.
88. Viswanathan AN, Dimopoulos JCA, Kirisits C, et al. CT versus MRI-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized Contours. Int J Radiat Oncol Biol Phys. 2007; 68: 491-8.
89. Shenfeld CB, Berger D, Dimopoulos JCA, et al. Systematic comparison of two methods of bladder contouring in cervix cancer brachytherapy: 'Direct' vs. 'indirect'. Brachytherapy. 2009; 8(2): 141-2.
90. Wachter-Gerstner N., Wachter S, Reinstadler E., et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol. 2003; 68(3): 269-76.
91. Olszewska AM, Saarnak AE, De Boer RW, et al. Comparison of dose-volume histograms and dose-wall histograms of the rectum of patients treated with intracavitary brachytherapy. Radiother Oncol. 2001; 61(1): 83-5.
92. Georg D, Kirisits C, Hillbrand M., et al. Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys. 2008; 71(4): 1272-8.
93. Lang S, Nulens A, Briot E., et al. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol. 2006; 78: 185-93.
94. Nulens A, Lang S, Briot E., et al. Evaluation of contouring concepts and dose volume parameters of MR based brachytherapy treatment plans for cervix cancer: results and conclusions of the GEC-ESTRO, GYN working group delineation workshops GEC-ESTRO Meeting, Budapest 2005. Radiother Oncol. 2005; 75(1):S9.
95. Petric P, Dimopoulos J, Kirisits C., et al. Inter- and intraobserver variation in HR CTV contouring: Intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol. 2008; 89(2): 164-71.
96. Kelly C, Thirion P, Grimley J., et al. Quantification of interobserver variation in delineation of target volumes using the GEC-ESTRO recommendations for MRI based brachytherapy of the cervix. Radiother Oncol. 2006; 81 suppl 1: 663.
97. Saarnak AE, Boersma M, van Bunningen BN, et al. Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer. Radiother Oncol. 2000; 56(1): 37-42.